Cell migration, a pivotal component of cancer cell behavior within the EMT pathway, was evaluated by quantifying the wound healing capability of MDA-MB-231 cells, both with and without HuR CRISPR, following an 18-h DTX treatment (Fig. 7D). This evidence concerns the gene ELAVL1 and cancer.